FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 330:868-869 March 24, 1994 Number 12 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

To the Editor: Cytomegalovirus retinitis is a leading cause of morbidity in patients with AIDS. Although it is optimally treated systemically with either ganciclovir or foscarnet, intraocular therapy is becoming increasingly popular. We report here the response of a patient to intravitreal foscarnet without concomitant systemic therapy.

The patient, a 59-year-old Hispanic man with AIDS, was given a diagnosis of cytomegalovirus retinitis of the left eye in November 1992 (Figure 1A). He was treated systemically with ganciclovir as induction therapy and then in maintenance doses.

View larger version (50K): [in this window] [in a new window]   Figure 1. Ophthalmoscopic Images of the Left Eye of a Patient with Cytomegalovirus Retinitis and . . . [Full Text of this Article]

 
References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.